G. Vergnault

Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug.

G Vergnault, P Langguth, P. Langguth, 2007, Advanced drug delivery reviews.

Modified release terbutaline (SKP1052) for hypoglycaemia prevention: a proof‐of‐concept study in people with type 1 diabetes mellitus

D. Owens, T. Heise, J. Cardot, 2012, Diabetes, obesity & metabolism.

Matrices containing NaCMC and HPMC 2. Swelling and release mechanism study.

L. Maggi, U. Conte, G. Vergnault, 2007, International journal of pharmaceutics.

Thermogravimetric investigation of the hydration behaviour of hydrophilic matrices.

L. Maggi, F. Pattarino, G. Vergnault, 2010, Journal of pharmaceutical sciences.

Evaluation of accelerated stability test conditions for medicated chewing gums

L. Maggi, U. Conte, G. Vergnault, 2013, Drug development and industrial pharmacy.

Use of dye as tracer of drug release from medicated chewing gums.

L. Maggi, U. Conte, G. Vergnault, 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Matrices containing NaCMC and HPMC 1. Dissolution performance characterization.

L. Maggi, U. Conte, G. Vergnault, 2007, International journal of pharmaceutics.

Evaluation of Nanosuspensions for Absorption Enhancement of Poorly Soluble Drugs: In Vitro Transport Studies Across Intestinal Epithelial Monolayers

P. Langguth, T. Lenhardt, G. Vergnault, 2008, The AAPS Journal.

Power of Experimental Design Studies for the Validation of Pharmaceutical Processes: Case Study of a Multilayer Tablet Manufacturing Process

F Goutte, F Guemguem, C Dragan, 2002, Drug development and industrial pharmacy.

Nanosuspension Formulations for Low-Soluble Drugs: Pharmacokinetic Evaluation Using Spironolactone as Model Compound

G Vergnault, P Langguth, P. Langguth, 2005, Drug development and industrial pharmacy.